Literature DB >> 7339802

Spectrum of clinical disease in pulmonary infection with Mycobacterium avium-intracellulare.

D Y Rosenzweig, D P Schlueter.   

Abstract

Cases of infection with Mycobacterium avium-intracellulare reported in Milwaukee, Wisconsin, have become more common in recent years, and their incidence--50 cases per year--is now similar to that of tuberculosis. Cases usually occur in middle-aged men with underlying lung diseases, but variations in age, sex, presentation, and severity of disease are wide. Several cases that illustrate pathogenesis and spectrum of disease, from primary, to chronic-active, to healing stages, are presented. The disease tends to run an indolent course in most cases, but extensive disease and unfavorable early course indicate poor prognosis. At a 10-year review, mortality had reached sizable numbers in this aging population with frequent serious underlying problems. Only a small number of these deaths can be attributed directly to mycobacterial disease.

Entities:  

Mesh:

Year:  1981        PMID: 7339802     DOI: 10.1093/clinids/3.5.1046

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  8 in total

Review 1.  Immunobiology of Mycobacterium avium infection.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 2.  AIDS-related mycobacterial disease.

Authors:  F M Collins
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Sex differences in host resistance to Mycobacterium marinum infection in mice.

Authors:  Y Yamamoto; H Saito; T Setogawa; H Tomioka
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 4.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

5.  Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages.

Authors:  G Plum; J E Clark-Curtiss
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex.

Authors:  K Suzuki; W J Lee; T Hashimoto; E Tanaka; T Murayama; R Amitani; K Yamamoto; F Kuze
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

Review 7.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

8.  Improved detection times for Mycobacterium avium complex and Mycobacterium tuberculosis with the BACTEC radiometric system.

Authors:  J M Kirihara; S L Hillier; M B Coyle
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.